Atlas Trials

A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects

Clinical trial NCT06732154 · COMPLETED

Trial details

NCT number
NCT06732154
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2024-12-02
Primary completion
2026-03-02
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.